NCT07056556 A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Other Solid Tumors Status RECRUITING Phase PHASE1
NCT07039994 Early Palliative Care in Patients With Advanced Lung Cancer Using an e-Health Ecosystem Status RECRUITING Phase NA
NCT07035444 Enteral Nutrition With L-Carnitine for Cachexia in Non-Small Cell Lung Cancer Status NOT_YET_RECRUITING Phase NA
NCT07034391 A Study Evaluating the Efficacy of PD-1 Inhibitor Combined With Denosumab and Chemotherapy in Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Patients With Driver Gene-Negative Status Status RECRUITING Phase PHASE2
NCT07034326 Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer Status RECRUITING Phase PHASE2/PHASE3
NCT07031154 A Single-arm, Multicenter, Prospective Clinical Study of Adebrelimab Combined With Apatinib Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT07030257 Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT07014202 Consolidation Radiotherapy vs. Observation in Oligoresidual Advanced Non-Small Cell Lung Cancer After Chemo-Immunotherapy Status RECRUITING Phase PHASE2
NCT07008287 Real-world Study of Taletrectinib for Advanced ROS1+ NSCLC With Brain Metastases Status RECRUITING Phase N/A
NCT07005401 Factors Determine the Feasibility and Surgical Margin Quality of Sublobar Resection for Non-small Cell Lung Cancer? Status COMPLETED Phase N/A
NCT06974097 Tumor Associated Neutrophils as a Biomarker of Chemo-immunotherapy Response in Locally Advanced Non-small Cell Lung Cancer : a Model Based on Neoadjuvant Strategy Status NOT_YET_RECRUITING Phase N/A
NCT06972576 Clinical Study of Combined EphA2-targeted CAR-DC and CAR-T Cell Therapy for Non-small Cell Lung Cancer Status RECRUITING Phase PHASE1
NCT06969027 JS207Combined With Chemotherapy in First-line Treatment of Advanced NSCLC Status RECRUITING Phase PHASE2
NCT06963502 A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1
NCT06962865 A Phase Ⅱ Study of RC108 in Combination With Furmonertinib for the First-line Treatment of EGFR-Mutated Combined MET-Positive Unresectable Locally Advanced or Recurrent Metastatic NSCLC Status RECRUITING Phase PHASE2
NCT06955325 Umbrella Trial of Adjuvant Therapy in Completely Resected High-risk Stage IA-IB NSCLC: Focus on Driver Mutations Status NOT_YET_RECRUITING Phase PHASE3
NCT06951464 A Study of BL-B01D1 and Almonertinib in Patients With Resectable EGFR+ Stage II-IIIB NSCLC Status RECRUITING Phase PHASE2
NCT06946797 A Study to Evaluate Two Dosing Regimens of Subcutaneous Nivolumab in Combination With Intravenous Ipilimumab and Chemotherapy in Participants With Previously Untreated Metastatic or Recurrent Non-Small Cell Lung Cancer (NSCLC) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06934590 Evaluate Safety and Tolerability of RX001 in Patients With KRAS Mutant Advanced NSCLC Status NOT_YET_RECRUITING Phase PHASE1